Evidence map›Paper›PMID 34174885›Full record

ArticleJournal of translational medicine2021

Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types.

Chris Bauer, Ralf Herwig, Matthias Lienhard, Paul Prasse, Tobias Scheffer, Johannes Schuchhardt

Abstract read
In one paragraph

Article in Journal of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chris BauerMicroDiscovery GmbH, Marienburger Straße 1, 10405, Berlin, Germany. chris.bauer@microdiscovery.de.ORCID 0000-0002-4199-5468
Ralf HerwigDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Ihnestraße 63, 14195, Berlin, Germany.
Matthias LienhardDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Ihnestraße 63, 14195, Berlin, Germany.
Paul PrasseDepartment of Informatics, University of Potsdam, August-Bebel-Str. 89, 14482, Potsdam, Germany.
Tobias SchefferDepartment of Informatics, University of Potsdam, August-Bebel-Str. 89, 14482, Potsdam, Germany.
Johannes SchuchhardtMicroDiscovery GmbH, Marienburger Straße 1, 10405, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a huge body of scientific literature describing the relation between tumor types and anti-cancer drugs. The vast amount of scientific literature makes it impossible for researchers and physicians to extract all relevant information manually.

methodsIn order to cope with the large amount of literature we applied an automated text mining approach to assess the relations between 30 most frequent cancer types and 270 anti-cancer drugs. We applied two different approaches, a classical text mining based on named entity recognition and an AI-based approach employing word embeddings. The consistency of literature mining results was validated with 3 independent methods: first, using data from FDA approvals, second, using experimentally measured IC-50 cell line data and third, using clinical patient survival data.

resultsWe demonstrated that the automated text mining was able to successfully assess the relation between cancer types and anti-cancer drugs. All validation methods showed a good correspondence between the results from literature mining and independent confirmatory approaches. The relation between most frequent cancer types and drugs employed for their treatment were visualized in a large heatmap. All results are accessible in an interactive web-based knowledge base using the following link: https://knowledgebase.microdiscovery.de/heatmap .

conclusionsOur approach is able to assess the relations between compounds and cancer types in an automated manner. Both, cancer types and compounds could be grouped into different clusters. Researchers can use the interactive knowledge base to inspect the presented results and follow their own research questions, for example the identification of novel indication areas for known drugs.

Indexed as

Antineoplastic AgentsNeoplasmsData MiningHumansKnowledge BasesPublicationsAntineoplastic AgentsAnti-cancer drugsDatabaseLiterature miningTumor typesWord embeddings

Identifiers

PMID34174885
PMCPMC8236166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.